PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9458834-3	1998	ANG II also increased prostaglandin E2 (PGE2) production by the MTAL in a dose-dependent manner and exerted biphasic differential effects on 86Rb uptake, depending on the exposure time of the tubules to the peptide and the doses used.	Rubidium-86	141-145	angiotensinogen	Homo sapiens	0-6	
9458834-4	1998	Low-dose ANG II (10(-11) M) increased 86Rb uptake by MTAL tubules after a "short-term" (15 min) challenge, whereas uptake was inhibited after a "long-term" (3 h) incubation period.	Rubidium-86	38-42	angiotensinogen	Homo sapiens	9-15	
9458834-5	1998	High-dose ANG II (10(-6) M) inhibited MTAL 86Rb uptake, irrespective of incubation time.	Rubidium-86	43-47	angiotensinogen	Homo sapiens	10-16	
9458834-6	1998	Uptake of 86Rb was inhibited by approximately 60% in MTAL tubules that were challenged for 3 h with ANG II.	Rubidium-86	10-14	angiotensinogen	Homo sapiens	100-106	
9458834-8	1998	We conclude that ANG II regulates TNF production in the MTAL, an interaction that affects 86Rb uptake via an eicosanoid-dependent mechanism in this nephron segment.	Rubidium-86	90-94	angiotensinogen	Homo sapiens	17-23	
366104-2	1978	Both phenylephrine and angiotensin II caused transient increases in 86Rb efflux from liver slices.	Rubidium-86	68-72	angiotensinogen	Homo sapiens	23-37	
6328908-4	1984	AII also stimulated ouabain-sensitive 86Rb+ uptake by cultured aortic smooth muscle and brain microvessel cells.	Rubidium-86	38-43	angiotensinogen	Homo sapiens	0-3	
1322364-5	1992	Angiotensin II caused rapid increases in both steady-state Na+, K(+)-ATPase activity (ouabain-sensitive 86Rb uptake) and intracellular [Na+].	Rubidium-86	104-108	angiotensinogen	Homo sapiens	0-14